|
Pluristem Therapeutics Inc. - Company Profile Snapshot
| Company Profile: |
Pluristem Therapeutics Inc. |
| Ticker: |
PSTI |
| Exchanges: |
NAS OTC |
| 2009 Sales: |
n/a |
| Major Industry: |
Drugs, Cosmetics & Health Care |
| Sub Industry: |
Ethical Drug Manufacturers |
| Country: |
UNITED STATES |
| Employees: |
34 |
Business Description
Pluristem Therapeutics Incorporation. Formerly known as Pluristem Life Systems, Inc.. The Group's principal activity is developing stem cell production technology and to commercialize cell therapy products. The Group's therapeutic products are used to improve the engraftment of hematopoietic stem cells in bone marrow transplants and expansion of hematopoietic stem cells found in umbilical cord blood. PLX-I is being developed as an allogeneic therapeutic product to supplement the UCB hematopoietic.
|
Not the Report you are looking for?
Click here for more browsing options.
|
The following information is available to subscribers or can be accessed by purchasing the Company Profile Report:
|
- Address (mailing), Phone Number, Web Address
- Earnings/Dividends
- Employees
- Exchanges Listed
- Financial Ratio Analysis |
- Recent Stock Performance
- Sales (recent year)
- Senior Officers
- Shareholder Information
- Stock Analysis Summary |
Layout and Content of a Typical Report
|
|
|
|
|
